Voya Investment Management LLC Corcept Therapeutics Inc Transaction History

Voya Investment Management LLC

  • $85.7 Billion
  • Q2 2024

A detailed history of Voya Investment Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 197,387 shares of CORT stock, worth $8.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
197,387
Previous 26,572 642.84%
Holding current value
$8.67 Million
Previous $669,000 858.59%
% of portfolio
0.01%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$22.21 - $34.48 $3.79 Million - $5.89 Million
170,815 Added 642.84%
197,387 $6.41 Million
Q1 2024

May 15, 2024
SELL
$21.1 - $27.46 $119,151 - $155,066
-5,647 Reduced 17.53%
26,572 $669,000
Q4 2023

Feb 14, 2024
SELL
$24.82 - $32.88 $2,779 - $3,682
-112 Reduced 0.35%
32,219 $1.05 Million
Q3 2023

Nov 14, 2023
SELL
$21.97 - $33.8 $4.72 Million - $7.27 Million
-215,040 Reduced 86.93%
32,331 $881,000
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $1.7 Million - $1.99 Million
-79,322 Reduced 24.28%
247,371 $5.5 Million
Q1 2023

May 15, 2023
BUY
$19.2 - $24.47 $4.04 Million - $5.15 Million
210,561 Added 181.31%
326,693 $7.08 Million
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $15,780 - $23,698
791 Added 0.69%
116,132 $2.36 Million
Q3 2022

Mar 03, 2023
SELL
$24.7 - $29.12 $19,537 - $23,033
-791 Reduced 0.68%
115,341 $2.96 Million
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $3.03 Million - $3.57 Million
-122,520 Reduced 51.51%
115,341 $2.96 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $3.49 Million - $5.1 Million
201,582 Added 555.64%
237,861 $5.66 Million
Q1 2022

May 16, 2022
SELL
$16.53 - $25.21 $20,778 - $31,688
-1,257 Reduced 3.35%
36,279 $817,000
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $14,227 - $19,418
-832 Reduced 2.17%
37,536 $743,000
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $22,317 - $25,549
-1,134 Reduced 2.87%
38,368 $755,000
Q2 2021

Aug 16, 2021
SELL
$19.97 - $24.43 $239,699 - $293,233
-12,003 Reduced 23.3%
39,502 $869,000
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $35,446 - $46,115
-1,509 Reduced 2.85%
51,505 $1.23 Million
Q4 2020

Feb 16, 2021
SELL
$16.78 - $27.3 $40,473 - $65,847
-2,412 Reduced 4.35%
53,014 $1.39 Million
Q3 2020

Nov 16, 2020
SELL
$12.46 - $19.98 $5,607 - $8,991
-450 Reduced 0.81%
55,426 $965,000
Q2 2020

Aug 14, 2020
SELL
$11.0 - $18.26 $159,995 - $265,591
-14,545 Reduced 20.65%
55,876 $940,000
Q1 2020

May 15, 2020
BUY
$10.11 - $14.04 $12,890 - $17,901
1,275 Added 1.84%
70,421 $837,000
Q4 2019

Feb 14, 2020
BUY
$12.06 - $16.96 $85,131 - $119,720
7,059 Added 11.37%
69,146 $837,000
Q3 2019

Nov 14, 2019
SELL
$10.41 - $14.66 $1,998 - $2,814
-192 Reduced 0.31%
62,087 $878,000
Q2 2019

Aug 14, 2019
SELL
$9.78 - $12.76 $12,606 - $16,447
-1,289 Reduced 2.03%
62,279 $694,000
Q1 2019

May 15, 2019
SELL
$10.03 - $15.71 $18,374 - $28,780
-1,832 Reduced 2.8%
63,568 $746,000
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $72,267 - $110,033
-6,401 Reduced 8.91%
65,400 $874,000
Q2 2018

Aug 14, 2018
SELL
$15.3 - $19.69 $19,614 - $25,242
-1,282 Reduced 1.75%
71,801 $1.13 Million
Q1 2018

May 15, 2018
SELL
$14.59 - $25.5 $21,388 - $37,383
-1,466 Reduced 1.97%
73,083 $1.2 Million
Q4 2017

Feb 14, 2018
BUY
$15.77 - $20.72 $519,637 - $682,744
32,951 Added 79.21%
74,549 $1.35 Million
Q3 2017

Nov 14, 2017
BUY
$12.3 - $19.3 $511,655 - $802,841
41,598
41,598 $803,000

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email